Financhill
Back

Chemomab Therapeutics Ltd. Stock Predictions

Chemomab Therapeutics Ltd. Stock Forecast

  • Is Chemomab Therapeutics Ltd. Stock Undervalued?
    The current Chemomab Therapeutics Ltd. [CMMB] share price is $1.89. The Score for CMMB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CMMB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Chemomab Therapeutics Ltd. Stock Go Up Next Year?

Data Unavailable

Chemomab Therapeutics Ltd. Stock Rating

Data Unavailable

Chemomab Therapeutics Ltd. Stock Price History

Is CMMB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMMB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
chemomab.com

52-Week Data

52-Week High:
9.84
52-Week Low:
1.73

Prediction Charts

Market Cap:
11.6M
Price in USD:
1.89
Volume:
138.7K
Beta:
0.66

Technical Analysis

SMA50:
2.72
SMA100:
2.98
SMA200:
3.94
52-Wk Change:
-70.83%

Stock Predictions

  • Is Chemomab Therapeutics Ltd. stock public?
    Yes, Chemomab Therapeutics Ltd. is a publicly traded company.
  • What is the Chemomab Therapeutics Ltd. stock quote today?
    The Chemomab Therapeutics Ltd. stock price is 1.89 USD today.
  • How to buy Chemomab Therapeutics Ltd. stock online?
    You can buy Chemomab Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 2.65 2.53 2.67 2.50
Dec-3 2.53 2.49 2.68 2.48
Dec-4 2.54 2.47 2.64 2.42
Dec-5 2.54 2.48 2.62 2.45
Dec-8 2.47 2.74 2.77 2.44
Dec-9 2.73 2.60 2.74 2.49
Dec-10 2.60 2.47 2.71 2.36
Dec-11 2.45 2.36 2.50 2.36
Dec-12 2.41 2.22 2.45 2.21
Dec-15 2.27 2.06 2.34 2.01
Dec-16 2.12 2.06 2.17 2.02
Dec-17 2.08 2.08 2.15 1.96
Dec-18 2.10 1.92 2.21 1.91
Dec-19 2.01 1.89 2.15 1.73

Chemomab Therapeutics Ltd. Earnings

Data Unavailable

Chemomab Therapeutics Ltd. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.12 per share.

* Chemomab Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.